A phase II, multicenter, single-arm study of tri-weekly low-dose nanoparticle albumin-bound paclitaxel chemotherapy for patients with metastatic or recurrent breast cancer.
Yamamoto S, Maeda N, Nagashima Y, Kubo H, Sato Y, Matsui H, Inoue Y, Shindo Y, Kanekiyo S, Sakamoto K, Suzuki N, Takeda S, Ueno T, Yoshino S, Hazama S, Oka M, Nagano H.
Yamamoto S, et al. Among authors: oka m.
Breast Cancer. 2017 Nov;24(6):783-789. doi: 10.1007/s12282-017-0779-7. Epub 2017 Apr 24.
Breast Cancer. 2017.
PMID: 28439763
Clinical Trial.